ID   VRK3_HUMAN              Reviewed;         474 AA.
AC   Q8IV63; A6NEG5; A8KA53; Q502Y2; Q9P2V8;
DT   10-OCT-2003, integrated into UniProtKB/Swiss-Prot.
DT   10-OCT-2003, sequence version 2.
DT   15-MAR-2017, entry version 140.
DE   RecName: Full=Inactive serine/threonine-protein kinase VRK3;
DE   AltName: Full=Serine/threonine-protein pseudokinase VRK3;
DE   AltName: Full=Vaccinia-related kinase 3;
GN   Name=VRK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Nezu J.;
RT   "Vaccinia related kinase 3 (VRK3).";
RL   Submitted (AUG-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Ni X., Xie Y., Mao Y.;
RT   "Cloning and characterization of a novel human VRK3 gene.";
RL   Submitted (MAY-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Testis, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=14645249; DOI=10.1074/jbc.M310813200;
RA   Nichols R.J., Traktman P.;
RT   "Characterization of three paralogous members of the Mammalian
RT   vaccinia related kinase family.";
RL   J. Biol. Chem. 279:7934-7946(2004).
RN   [7]
RP   INTERACTION WITH RAN.
RX   PubMed=18617507; DOI=10.1074/mcp.M700586-MCP200;
RA   Sanz-Garcia M., Lopez-Sanchez I., Lazo P.A.;
RT   "Proteomics identification of nuclear Ran GTPase as an inhibitor of
RT   human VRK1 and VRK2 (vaccinia-related kinase) activities.";
RL   Mol. Cell. Proteomics 7:2199-2214(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55 AND SER-59, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-83 AND SER-90,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-83, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-83; SER-115 AND
RP   SER-122, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54; SER-59 AND SER-83,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 146-474, FUNCTION, AND LACK
RP   OF CATALYTIC ACTIVITY.
RX   PubMed=19141289; DOI=10.1016/j.str.2008.10.018;
RA   Scheeff E.D., Eswaran J., Bunkoczi G., Knapp S., Manning G.;
RT   "Structure of the pseudokinase VRK3 reveals a degraded catalytic site,
RT   a highly conserved kinase fold, and a putative regulatory binding
RT   site.";
RL   Structure 17:128-138(2009).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] PHE-59; THR-105; LEU-171; LEU-268;
RP   TYR-288; CYS-370 AND GLY-371.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Inactive kinase that suppresses ERK activity by
CC       promoting phosphatase activity of DUSP3 which specifically
CC       dephosphorylates and inactivates ERK in the nucleus. {ECO:0000250,
CC       ECO:0000269|PubMed:14645249, ECO:0000269|PubMed:19141289}.
CC   -!- SUBUNIT: Interacts with DUSP3 (By similarity). Interacts with RAN.
CC       {ECO:0000250, ECO:0000269|PubMed:18617507}.
CC   -!- INTERACTION:
CC       P61244:MAX; NbExp=2; IntAct=EBI-1058605, EBI-751711;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14645249}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q8IV63-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8IV63-2; Sequence=VSP_008544, VSP_008545;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q8IV63-3; Sequence=VSP_043409;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CK1 Ser/Thr
CC       protein kinase family. VRK subfamily. {ECO:0000305}.
CC   -!- CAUTION: Inactive as a kinase due to its inability to bind ATP.
CC       {ECO:0000305|PubMed:19141289}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB031052; BAA90769.1; -; mRNA.
DR   EMBL; AF514788; AAP47180.1; -; mRNA.
DR   EMBL; AK292918; BAF85607.1; -; mRNA.
DR   EMBL; AK303010; BAG64141.1; -; mRNA.
DR   EMBL; AC011452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC023556; AAH23556.1; -; mRNA.
DR   EMBL; BC095449; AAH95449.1; -; mRNA.
DR   CCDS; CCDS12791.1; -. [Q8IV63-1]
DR   CCDS; CCDS33076.1; -. [Q8IV63-3]
DR   CCDS; CCDS77334.1; -. [Q8IV63-2]
DR   RefSeq; NP_001020949.1; NM_001025778.1. [Q8IV63-3]
DR   RefSeq; NP_001295349.1; NM_001308420.1. [Q8IV63-2]
DR   RefSeq; NP_057524.3; NM_016440.3. [Q8IV63-1]
DR   RefSeq; XP_005259028.1; XM_005258971.3. [Q8IV63-1]
DR   RefSeq; XP_005259029.1; XM_005258972.3. [Q8IV63-3]
DR   RefSeq; XP_006723300.1; XM_006723237.3. [Q8IV63-1]
DR   RefSeq; XP_006723301.1; XM_006723238.3. [Q8IV63-3]
DR   RefSeq; XP_011525325.1; XM_011527023.2. [Q8IV63-2]
DR   UniGene; Hs.443330; -.
DR   PDB; 2JII; X-ray; 2.00 A; A/B=146-474.
DR   PDBsum; 2JII; -.
DR   ProteinModelPortal; Q8IV63; -.
DR   SMR; Q8IV63; -.
DR   BioGrid; 119394; 11.
DR   IntAct; Q8IV63; 11.
DR   MINT; MINT-8247443; -.
DR   STRING; 9606.ENSP00000324636; -.
DR   ChEMBL; CHEMBL3430761; -.
DR   iPTMnet; Q8IV63; -.
DR   PhosphoSitePlus; Q8IV63; -.
DR   BioMuta; VRK3; -.
DR   DMDM; 45593724; -.
DR   EPD; Q8IV63; -.
DR   MaxQB; Q8IV63; -.
DR   PaxDb; Q8IV63; -.
DR   PeptideAtlas; Q8IV63; -.
DR   PRIDE; Q8IV63; -.
DR   TopDownProteomics; Q8IV63-1; -. [Q8IV63-1]
DR   DNASU; 51231; -.
DR   Ensembl; ENST00000316763; ENSP00000324636; ENSG00000105053. [Q8IV63-1]
DR   Ensembl; ENST00000377011; ENSP00000366210; ENSG00000105053. [Q8IV63-3]
DR   Ensembl; ENST00000594092; ENSP00000472541; ENSG00000105053. [Q8IV63-2]
DR   Ensembl; ENST00000594948; ENSP00000473171; ENSG00000105053. [Q8IV63-1]
DR   Ensembl; ENST00000599538; ENSP00000469880; ENSG00000105053. [Q8IV63-1]
DR   Ensembl; ENST00000601341; ENSP00000470156; ENSG00000105053. [Q8IV63-3]
DR   GeneID; 51231; -.
DR   KEGG; hsa:51231; -.
DR   UCSC; uc002prg.3; human. [Q8IV63-1]
DR   CTD; 51231; -.
DR   GeneCards; VRK3; -.
DR   HGNC; HGNC:18996; VRK3.
DR   HPA; HPA056489; -.
DR   neXtProt; NX_Q8IV63; -.
DR   OpenTargets; ENSG00000105053; -.
DR   PharmGKB; PA134923990; -.
DR   eggNOG; KOG1164; Eukaryota.
DR   eggNOG; ENOG410XPGP; LUCA.
DR   GeneTree; ENSGT00850000132311; -.
DR   HOGENOM; HOG000293191; -.
DR   HOVERGEN; HBG047756; -.
DR   InParanoid; Q8IV63; -.
DR   KO; K08816; -.
DR   OMA; YEEKPPY; -.
DR   OrthoDB; EOG091G05V5; -.
DR   PhylomeDB; Q8IV63; -.
DR   TreeFam; TF106473; -.
DR   Reactome; R-HSA-202670; ERKs are inactivated.
DR   SignaLink; Q8IV63; -.
DR   ChiTaRS; VRK3; human.
DR   EvolutionaryTrace; Q8IV63; -.
DR   GenomeRNAi; 51231; -.
DR   PRO; PR:Q8IV63; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105053; -.
DR   CleanEx; HS_VRK3; -.
DR   ExpressionAtlas; Q8IV63; baseline and differential.
DR   Genevisible; Q8IV63; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0019903; F:protein phosphatase binding; IDA:MGI.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IEA:Ensembl.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0032516; P:positive regulation of phosphoprotein phosphatase activity; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR026870; Zinc_ribbon_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF13240; zinc_ribbon_2; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    474       Inactive serine/threonine-protein kinase
FT                                VRK3.
FT                                /FTId=PRO_0000086808.
FT   DOMAIN      166    457       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF        49     64       Nuclear localization signal.
FT                                {ECO:0000269|PubMed:14645249}.
FT   MOD_RES      54     54       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      59     59       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      82     82       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692}.
FT   MOD_RES      83     83       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      90     90       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     115    115       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     122    122       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ      47     96       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043409.
FT   VAR_SEQ     407    412       FVDKPG -> LPWDSF (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008544.
FT   VAR_SEQ     413    474       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_008545.
FT   VARIANT      59     59       S -> F (in dbSNP:rs2033262).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041295.
FT   VARIANT     105    105       P -> T (in dbSNP:rs11547882).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041296.
FT   VARIANT     170    170       S -> P (in dbSNP:rs11547881).
FT                                /FTId=VAR_051682.
FT   VARIANT     171    171       F -> L (in dbSNP:rs11547883).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041297.
FT   VARIANT     188    188       T -> A (in dbSNP:rs11879620).
FT                                /FTId=VAR_051683.
FT   VARIANT     268    268       S -> L (in dbSNP:rs10410075).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041298.
FT   VARIANT     288    288       C -> Y (in dbSNP:rs10409482).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041299.
FT   VARIANT     304    304       H -> L (in dbSNP:rs35261919).
FT                                /FTId=VAR_051684.
FT   VARIANT     370    370       R -> C (in dbSNP:rs35331034).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041300.
FT   VARIANT     371    371       S -> G (in dbSNP:rs56407496).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041301.
FT   CONFLICT    161    161       K -> E (in Ref. 2; AAP47180).
FT                                {ECO:0000305}.
FT   STRAND      157    159       {ECO:0000244|PDB:2JII}.
FT   STRAND      165    175       {ECO:0000244|PDB:2JII}.
FT   STRAND      178    185       {ECO:0000244|PDB:2JII}.
FT   STRAND      200    206       {ECO:0000244|PDB:2JII}.
FT   HELIX       211    221       {ECO:0000244|PDB:2JII}.
FT   HELIX       224    233       {ECO:0000244|PDB:2JII}.
FT   STRAND      246    250       {ECO:0000244|PDB:2JII}.
FT   TURN        251    253       {ECO:0000244|PDB:2JII}.
FT   STRAND      254    260       {ECO:0000244|PDB:2JII}.
FT   HELIX       266    272       {ECO:0000244|PDB:2JII}.
FT   HELIX       274    276       {ECO:0000244|PDB:2JII}.
FT   HELIX       280    299       {ECO:0000244|PDB:2JII}.
FT   STRAND      311    315       {ECO:0000244|PDB:2JII}.
FT   STRAND      318    324       {ECO:0000244|PDB:2JII}.
FT   HELIX       327    329       {ECO:0000244|PDB:2JII}.
FT   HELIX       335    337       {ECO:0000244|PDB:2JII}.
FT   TURN        354    356       {ECO:0000244|PDB:2JII}.
FT   HELIX       359    362       {ECO:0000244|PDB:2JII}.
FT   HELIX       369    385       {ECO:0000244|PDB:2JII}.
FT   HELIX       391    393       {ECO:0000244|PDB:2JII}.
FT   HELIX       397    409       {ECO:0000244|PDB:2JII}.
FT   HELIX       426    436       {ECO:0000244|PDB:2JII}.
FT   HELIX       446    459       {ECO:0000244|PDB:2JII}.
SQ   SEQUENCE   474 AA;  52881 MW;  86B9B91050A7F0CC CRC64;
     MISFCPDCGK SIQAAFKFCP YCGNSLPVEE HVGSQTFVNP HVSSFQGSKR GLNSSFETSP
     KKVKWSSTVT SPRLSLFSDG DSSESEDTLS SSERSKGSGS RPPTPKSSPQ KTRKSPQVTR
     GSPQKTSCSP QKTRQSPQTL KRSRVTTSLE ALPTGTVLTD KSGRQWKLKS FQTRDNQGIL
     YEAAPTSTLT CDSGPQKQKF SLKLDAKDGR LFNEQNFFQR AAKPLQVNKW KKLYSTPLLA
     IPTCMGFGVH QDKYRFLVLP SLGRSLQSAL DVSPKHVLSE RSVLQVACRL LDALEFLHEN
     EYVHGNVTAE NIFVDPEDQS QVTLAGYGFA FRYCPSGKHV AYVEGSRSPH EGDLEFISMD
     LHKGCGPSRR SDLQSLGYCM LKWLYGFLPW TNCLPNTEDI MKQKQKFVDK PGPFVGPCGH
     WIRPSETLQK YLKVVMALTY EEKPPYAMLR NNLEALLQDL RVSPYDPIGL PMVP
//
